オートインジェクター市場は、2024年の14億ドルから2030年には30億2000万ドルに成長し、予測期間中のCAGRは13.6%になると予想されます。デバイスのオートインジェクター市場のプレーヤーには、SHL Medical AG(スイス)、Ypsomed AG(スイス)、Becton、Dickinson and Company(BD)(米国)、Recipharm AB(スウェーデン)、West Pharmaceutical Services、Inc.(米国)、Phillips-Medisize(米国)、Halozyme、Inc.(米国)、Owen Mumford Ltd.(英国)、Gerresheimer AG(ドイツ)、Haselmeier(ドイツ)、Oval Medical Technologies Ltd.(英国)、Kaleo、Inc.(米国)、Solteam Incorporation Co.、Ltd.(中国)、Elcam Drug Delivery Devices(イスラエル)、 Crossject(フランス)、Jabil, Inc.(米国)、Congruence Medical Solutions LLC(米国)、Midas Pharma GMBH(ドイツ)この章で取り上げる最終製剤の主要な市場プレーヤーには、Abbvie Inc.(米国)、Eli Lilly and Company(米国)、Amgen Inc.(米国)、Novo Nordisk A/S(デンマーク)、Jonhson & Jonhson Services Inc.(米国)、Sanofi(フランス)、GSK plc(英国)などがあります。
目次
TABLE OF CONTENTS
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS (Page No. - 66)
4.1 AUTOINJECTORS MARKET OVERVIEW
4.2 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET, BY USAGE AND COUNTRY (2023)
4.3 NORTH AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION AND COUNTRY (2023)
4.4 AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2024 VS. 2030 (USD MILLION)
4.5 AUTOINJECTORS MARKET SHARE, BY TECHNOLOGY, 2023
4.6 AUTOINJECTOR DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.7 AUTOINJECTOR FINISHED FORMULATIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW (Page No. - 71)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of chronic diseases
5.2.1.2 Increasing regulatory approvals for autoinjectors
5.2.1.3 High demand for biosimilars and biologics
5.2.1.4 Growing adoption of self-administered medicines
5.2.1.5 Government support and favorable reimbursement policies
5.2.2 RESTRAINTS
5.2.2.1 Focus on needle-free drug delivery systems and prevalence of needle phobia
5.2.3 OPPORTUNITIES
5.2.3.1 Impending patent expiry of biological molecules
5.2.3.2 Launch of technologically-advanced autoinjectors
5.2.4 CHALLENGES
5.2.4.1 Development of autoinjectors for multiple drug viscosities
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4 VALUE CHAIN ANALYSIS
5.4.1 VALUE CHAIN ANALYSIS: AUTOINJECTOR DEVICE MANUFACTURERS (PLATFORM PROVIDERS)
5.4.2 VALUE CHAIN ANALYSIS: AUTOINJECTOR FINISHED FORMULATION MANUFACTURERS
5.5 SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.6.1 AUTOINJECTOR PROVIDERS
5.6.2 END USERS
5.6.3 REGULATORY BODIES
5.7 REGULATORY ANALYSIS
5.7.1 REGULATORY LANDSCAPE
5.7.1.1 North America
5.7.1.2 Europe
5.7.1.3 Asia Pacific
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.2.1 North America
5.7.2.2 Europe
5.7.2.3 Asia Pacific
5.7.2.4 Rest of the World
5.8 PORTER’S FIVE FORCES ANALYSIS
5.8.1 INTENSITY OF COMPETITIVE RIVALRY
5.8.2 BARGAINING POWER OF SUPPLIERS
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 THREAT OF SUBSTITUTES
5.8.5 THREAT OF NEW ENTRANTS
5.9 TRADE DATA ANALYSIS
5.9.1 IMPORT DATA FOR PRODUCTS (INCLUDING AUTOINJECTORS)
5.9.2 EXPORT DATA FOR PRODUCTS (INCLUDING AUTOINJECTORS)
5.10 TECHNOLOGY ANALYSIS
5.10.1 KEY TECHNOLOGIES
5.10.1.1 Injection mechanism technology
5.10.1.2 Electronic and connectivity solutions
5.10.2 ADJACENT TECHNOLOGIES
5.10.2.1 Wearable drug delivery devices
5.10.2.2 Implantable drug delivery systems
5.10.3 COMPLEMENTARY TECHNOLOGIES
5.10.3.1 Power assistance mechanisms
5.10.3.2 Advanced needle technology
5.11 PATENT ANALYSIS
5.11.1 METHODOLOGY
5.11.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE
5.11.3 INNOVATION AND PATENT APPLICATIONS
5.11.4 TOP APPLICANTS FOR PATENTS
5.12 INDICATIVE PRICING ANALYSIS
5.12.1 AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE
5.12.2 AVERAGE SELLING PRICE TREND, BY USAGE
5.12.3 INDICATIVE AUTOINJECTOR FINISHED FORMULATIONS PRICING ANALYSIS, BY KEY PLAYER
5.12.4 INDICATIVE AUTOINJECTOR FINISHED FORMULATIONS PRICING ANALYSIS, BY REGION
5.13 KEY CONFERENCES AND EVENTS, 2024-2025
5.14 INVESTMENT AND FUNDING SCENARIO
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.15.1.1 Key stakeholders in buying process for autoinjector devices
5.15.1.2 Key stakeholders in buying process for autoinjector finished formulations
5.15.2 KEY BUYING CRITERIA
5.15.2.1 Key buying criteria for autoinjector devices
5.15.2.2 Key buying criteria for autoinjector finished formulations
5.16 IMPACT OF GENERATIVE AI ON AUTOINJECTORS MARKET
6 AUTOINJECTORS MARKET, BY USAGE (Page No. - 111)
6.1 INTRODUCTION
6.2 DISPOSABLE AUTOINJECTORS
6.2.1 EASE OF USE AND REDUCED RISK OF NEEDLESTICK INJURIES TO PROPEL MARKET GROWTH
6.3 REUSABLE AUTOINJECTORS
6.3.1 COST-EFFECTIVENESS, VERSATILITY, AND SUSTAINABILITY TO FUEL MARKET GROWTH
7 AUTOINJECTORS MARKET, BY TECHNOLOGY (Page No. - 124)
7.1 INTRODUCTION
7.2 MANUAL AUTOINJECTORS
7.2.1 USER-FRIENDLY DESIGN AND INCREASED PATIENT CONTROL TO AUGMENT MARKET GROWTH
7.3 AUTOMATIC AUTOINJECTORS
7.3.1 EASE OF ACCURATE DOCUMENTATION AND COMPREHENSIVE PATIENT RECORDS TO SUPPORT MARKET GROWTH
8 AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION (Page No. - 137)
8.1 INTRODUCTION
8.2 SUBCUTANEOUS ROUTE OF ADMINISTRATION
8.2.1 EASE OF USE, RAPID ABSORPTION, AND SUITABILITY FOR SELF-ADMINISTRATION TO AID MARKET GROWTH
8.3 INTRAMUSCULAR ROUTE OF ADMINISTRATION
8.3.1 NEED FOR PRECISE DOSE DELIVERY IN EMERGENCY CLINICAL SETTINGS TO DRIVE MARKET
9 AUTOINJECTORS MARKET, BY THERAPY AREA (Page No. - 145)
9.1 INTRODUCTION
9.2 RHEUMATOID ARTHRITIS
9.2.1 HIGH DISEASE PREVALENCE AND NEED FOR FREQUENT DOSING TO DRIVE MARKET
9.3 DIABETES
9.3.1 LARGE DIABETIC POPULATION AND EASE OF ADMINISTRATION TO STIMULATE DEMAND
9.4 MULTIPLE SCLEROSIS
9.4.1 AVAILABILITY OF COST-EFFECTIVE GENERIC ORAL MULTIPLE SCLEROSIS DRUGS TO LIMIT MARKET GROWTH
9.5 ANAPHYLAXIS
9.5.1 REQUIREMENT FOR PROMPT INITIAL TREATMENT FOR PATIENTS WITH FOOD ALLERGIES TO FUEL MARKET GROWTH
9.6 OBESITY
9.6.1 INCREASING FOCUS ON WEIGHT MANAGEMENT TO BOOST MARKET GROWTH
9.7 OTHER THERAPY AREAS
10 AUTOINJECTORS MARKET, BY VOLUME (Page No. - 180)
10.1 INTRODUCTION
10.2 UP TO 3ML VOLUME AUTOINJECTORS
10.2.1 RISING PREVALENCE OF AUTOIMMUNE DISORDERS AND LONG-TERM CHRONIC DISEASES TO PROPEL MARKET GROWTH
10.3 ABOVE 3ML VOLUME AUTOINJECTORS
10.3.1 INCREASING FOCUS ON COMPLEX TREATMENTS WITH HIGH-VISCOSITY DRUGS TO DRIVE MARKET
11 AUTOINJECTORS MARKET, BY END USER (Page No. - 184)
11.1 INTRODUCTION
11.2 HOME CARE SETTINGS
11.2.1 COST-EFFECTIVENESS AND INCREASED AVAILABILITY OF HOME CARE SUPPORT SERVICES TO PROPEL MARKET GROWTH
11.3 HOSPITALS & CLINICS
11.3.1 TECHNOLOGICAL ADVANCEMENTS AND AVAILABILITY OF REAL-TIME PATIENT DATA TO SUPPORT MARKET GROWTH
11.4 AMBULATORY CARE SETTINGS
11.4.1 GROWING DEMAND FOR OUTPATIENT SERVICES TO FUEL MARKET GROWTH
12 AUTOINJECTORS MARKET, BY REGION (Page No. - 194)
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 US
12.2.1.1 US to dominate North American autoinjectors market during forecast period
12.2.2 CANADA
12.2.2.1 Rising geriatric population and increasing prevalence of food allergies to propel market growth
12.3 EUROPE
12.3.1 GERMANY
12.3.1.1 Favorable government initiatives and regulatory trends to aid market growth
12.3.2 UK
12.3.2.1 High prevalence of allergic conditions and increased incidence of lifestyle diseases to boost market growth
12.3.3 FRANCE
12.3.3.1 High prevalence of diabetes and favorable reimbursement policies to support market
12.3.4 ITALY
12.3.4.1 Rising healthcare expenditure and increasing geriatric population to augment market growth
12.3.5 SPAIN
12.3.5.1 Favorable reimbursement scenario and presence of universal health coverage facility to aid market growth
12.3.6 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 JAPAN
12.4.1.1 Large geriatric population and improved healthcare infrastructure to drive market
12.4.2 CHINA
12.4.2.1 Increasing prevalence of food allergies and anaphylaxis to fuel market growth
12.4.3 INDIA
12.4.3.1 Increasing burden of diabetes and cardiovascular diseases to spur market growth
12.4.4 SOUTH KOREA
12.4.4.1 Increased regulatory approvals and strong clinical pipeline by domestic players to propel market
12.4.5 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 BRAZIL
12.5.1.1 Rising adoption of autoinjectors and growing prevalence of chronic diseases to augment market growth
12.5.2 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 GCC COUNTRIES
12.6.1.1 High healthcare spending capacity and favorable regulatory scenario to drive market
12.6.2 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE (Page No. - 291)
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN AUTOINJECTORS MARKET
13.3 REVENUE ANALYSIS
13.3.1 REVENUE ANALYSIS: AUTOINJECTOR DEVICES MARKET
13.3.2 REVENUE ANALYSIS: AUTOINJECTOR FINISHED FORMULATIONS MARKET
13.4 MARKET SHARE ANALYSIS
13.4.1 MARKET SHARE ANALYSIS: AUTOINJECTOR DEVICES MARKET
13.4.2 MARKET SHARE ANALYSIS: AUTOINJECTOR FINISHED FORMULATIONS MARKET
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
13.5.1 AUTOINJECTOR DEVICES MARKET: COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
13.5.1.1 Stars
13.5.1.2 Emerging leaders
13.5.1.3 Pervasive players
13.5.1.4 Participants
13.5.2 AUTOINJECTOR FINISHED FORMULATIONS MARKET: COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
13.5.2.1 Stars
13.5.2.2 Emerging leaders
13.5.2.3 Pervasive players
13.5.2.4 Participants
13.5.3 COMPANY FOOTPRINT: KEY PLAYERS, 2023
13.5.3.1 Company footprint
13.5.3.2 Region footprint
13.5.3.3 Usage footprint
13.5.3.4 Volume footprint
13.5.3.5 Route of administration footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
13.7 COMPANY VALUATION AND FINANCIAL METRICS
13.7.1 FINANCIAL METRICS
13.7.2 COMPANY VALUATION
13.8 BRAND/PRODUCT COMPARISON
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES AND APPROVALS
13.9.2 DEALS
13.9.3 EXPANSIONS
13.10 DEVICES FOR LARGE-VOLUME FORMULATIONS
13.11 DEVICES FOR HIGHLY VISCOUS FORMULATIONS
13.12 INSIGHTS ON FUTURE AREAS OF FOCUS IN AUTOINJECTORS MARKET
14 COMPANY PROFILES (Page No. - 320)
14.1 KEY PLAYERS: AUTOINJECTOR DEVICES MARKET
14.1.1 SHL MEDICAL AG
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Product launches
14.1.1.3.2 Deals
14.1.1.3.3 Expansions
14.1.1.4 MnM view
14.1.1.4.1 Key strengths
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses and competitive threats
14.1.2 YPSOMED AG
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Product launches
14.1.2.3.2 Deals
14.1.2.3.3 Expansions
14.1.2.4 MnM view
14.1.2.4.1 Key strengths
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses and competitive threats
14.1.3 BECTON, DICKINSON AND COMPANY (BD)
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 Recent developments
14.1.3.3.1 Deals
14.1.3.3.2 Other developments
14.1.3.4 MnM view
14.1.3.4.1 Key strengths
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses and competitive threats
14.1.4 RECIPHARM AB
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.5 WEST PHARMACEUTICAL SERVICES, INC.
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.3.1 Expansions
14.1.6 PHILLIPS-MEDISIZE
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.6.3 Recent developments
14.1.6.3.1 Product launches
14.1.7 HALOZYME, INC.
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.8 OWEN MUMFORD LTD.
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Product launches
14.1.8.3.2 Deals
14.1.8.3.3 Expansions
14.2 KEY PLAYERS: AUTOINJECTOR FINISHED FORMULATIONS MARKET
14.2.1 ABBVIE INC.
14.2.1.1 Business overview
14.2.1.2 Products offered
14.2.1.3 Recent developments
14.2.1.3.1 Product launches and approvals
14.2.2 ELI LILLY AND COMPANY
14.2.2.1 Business overview
14.2.2.2 Products offered
14.2.2.3 Recent developments
14.2.2.3.1 Product approvals
14.2.2.3.2 Deals
14.2.3 AMGEN INC.
14.2.3.1 Business overview
14.2.3.2 Products offered
14.2.3.3 Recent developments
14.2.3.3.1 Product launches
14.2.4 NOVO NORDISK A/S
14.2.4.1 Business overview
14.2.4.2 Products offered
14.2.4.3 Recent developments
14.2.4.3.1 Product approvals
14.2.4.3.2 Deals
14.2.4.3.3 Expansions
14.2.4.3.4 Other developments
14.2.5 JOHNSON & JOHNSON SERVICES, INC.
14.2.5.1 Business overview
14.2.5.2 Products offered
14.2.6 SANOFI
14.2.6.1 Business overview
14.2.6.2 Products offered
14.2.7 GSK PLC
14.2.7.1 Business overview
14.2.7.2 Products offered
14.2.7.3 Recent developments
14.2.7.3.1 Product approvals
14.3 OTHER PLAYERS
14.3.1 GERRESHEIMER AG
14.3.2 HASELMEIER
14.3.3 OVAL MEDICAL TECHNOLOGIES LTD.
14.3.4 KALEO, INC.
14.3.5 SOLTEAM INCORPORATION CO., LTD.
14.3.6 ELCAM DRUG DELIVERY DEVICES
14.3.7 CROSSJECT
14.3.8 JABIL INC.
14.3.9 CONGRUENCE MEDICAL SOLUTIONS LLC
14.3.10 MIDAS PHARMA GMBH
15 APPENDIX (Page No. - 373)
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
LIST OF TABLES (527 TABLES)
TABLE 1 AUTOINJECTORS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS ON AUTOINJECTORS MARKET
TABLE 3 RECENT APPROVALS OF AUTOINJECTOR BIOLOGICS IN US AND EUROPE, 2020-2024
TABLE 4 PATENT EXPIRY OF KEY BIOLOGICS
TABLE 5 LIST OF KEY AUTOINJECTOR DEVICE PROVIDERS
TABLE 6 LIST OF KEY AUTOINJECTOR FINISHED FORMULATION PRODUCT PROVIDERS
TABLE 7 LIST OF KEY END USERS
TABLE 8 LIST OF KEY REGULATORY BODIES
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 AUTOINJECTORS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 14 IMPORT DATA FOR PRODUCTS (INCLUDING AUTOINJECTORS), 2021-2023 (USD MILLION)
TABLE 15 EXPORT DATA FOR PRODUCTS (INCLUDING AUTOINJECTORS), 2021-2023 (USD MILLION)
TABLE 16 LIST OF ADVANTAGES AND DISADVANTAGES OF AUTOINJECTOR TECHNOLOGIES
TABLE 17 NUMBER OF PATENTS FILED IN AUTOINJECTORS MARKET, 2014-2024
TABLE 18 TOP 10 PATENT OWNERS IN US IN AUTOINJECTORS MARKET, 2014-2024
TABLE 19 DETAILED ANALYSIS OF KEY PATENTS IN AUTOINJECTORS MARKET, 2022-2024
TABLE 20 INDICATIVE PRICING OF FINISHED FORMULATION PRODUCTS, BY KEY PLAYER, 2023
TABLE 21 INDICATIVE PRICING ANALYSIS OF THERAPY AREAS FOR AUTOINJECTOR FINISHED FORMULATIONS, BY REGION, 2023
TABLE 22 AUTOINJECTORS MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS, JANUARY 2024-DECEMBER 2025
TABLE 23 AUTOINJECTOR DEVICES MARKET: INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
TABLE 24 AUTOINJECTOR FINISHED FORMULATIONS MARKET: INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
TABLE 25 AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 26 AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (MILLION UNITS)
TABLE 27 AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 28 DISPOSABLE AUTOINJECTOR DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 29 DISPOSABLE AUTOINJECTOR DEVICES MARKET, BY REGION, 2022-2030 (MILLION UNITS)
TABLE 30 NORTH AMERICA: DISPOSABLE AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 31 EUROPE: DISPOSABLE AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 32 ASIA PACIFIC: DISPOSABLE AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 33 LATIN AMERICA: DISPOSABLE AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA: DISPOSABLE AUTOINJECTOR DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 35 DISPOSABLE AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 36 NORTH AMERICA: DISPOSABLE AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 37 EUROPE: DISPOSABLE AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 38 ASIA PACIFIC: DISPOSABLE AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 39 LATIN AMERICA: DISPOSABLE AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA: DISPOSABLE AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 41 REUSABLE AUTOINJECTOR DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 42 REUSABLE AUTOINJECTOR DEVICES MARKET, BY REGION, 2022-2030 (MILLION UNITS)
TABLE 43 NORTH AMERICA: REUSABLE AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 44 EUROPE: REUSABLE AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 45 ASIA PACIFIC: REUSABLE AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 46 LATIN AMERICA: REUSABLE AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 47 MIDDLE EAST & AFRICA: REUSABLE AUTOINJECTOR DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 48 REUSABLE AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 49 NORTH AMERICA: REUSABLE AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 50 EUROPE: REUSABLE AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 51 ASIA PACIFIC: REUSABLE AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 52 LATIN AMERICA: REUSABLE AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 53 MIDDLE EAST & AFRICA: REUSABLE AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 54 AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 55 AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (MILLION UNITS)
TABLE 56 AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 57 MANUAL AUTOINJECTOR DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 58 MANUAL AUTOINJECTOR DEVICES MARKET, BY REGION, 2022-2030 (MILLION UNITS)
TABLE 59 NORTH AMERICA: MANUAL AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 60 EUROPE: MANUAL AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 61 ASIA PACIFIC: MANUAL AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 62 LATIN AMERICA: MANUAL AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 63 MIDDLE EAST & AFRICA: MANUAL AUTOINJECTOR DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 64 MANUAL AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 65 NORTH AMERICA: MANUAL AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 66 EUROPE: MANUAL AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 67 ASIA PACIFIC: MANUAL AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 68 LATIN AMERICA: MANUAL AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 69 MIDDLE EAST & AFRICA: MANUAL AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 70 AUTOMATIC AUTOINJECTOR DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 71 AUTOMATIC AUTOINJECTOR DEVICES MARKET, BY REGION, 2022-2030 (MILLION UNITS)
TABLE 72 NORTH AMERICA: AUTOMATIC AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 73 EUROPE: AUTOMATIC AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 74 ASIA PACIFIC: AUTOMATIC AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 75 LATIN AMERICA: AUTOMATIC AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 76 MIDDLE EAST & AFRICA: AUTOMATIC AUTOINJECTOR DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 77 AUTOMATIC AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 78 NORTH AMERICA: AUTOMATIC AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 79 EUROPE: AUTOMATIC AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 80 ASIA PACIFIC: AUTOMATIC AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 81 LATIN AMERICA: AUTOMATIC AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 82 MIDDLE EAST & AFRICA: AUTOMATIC AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 83 AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 84 AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (MILLION UNITS)
TABLE 85 AUTOINJECTOR DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF ADMINISTRATION, BY REGION, 2022-2030 (USD MILLION)
TABLE 86 AUTOINJECTOR DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF ADMINISTRATION, BY REGION, 2022-2030 (MILLION UNITS)
TABLE 87 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF ADMINISTRATION, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 88 EUROPE: AUTOINJECTOR DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF ADMINISTRATION, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 89 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF ADMINISTRATION, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 90 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF ADMINISTRATION, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 91 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF ADMINISTRATION, BY REGION, 2022-2030 (USD MILLION)
TABLE 92 AUTOINJECTOR DEVICES MARKET FOR INTRAMUSCULAR ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 93 AUTOINJECTOR DEVICES MARKET FOR INTRAMUSCULAR ROUTE OF ADMINISTRATION, 2022-2030 (MILLION UNITS)
TABLE 94 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET FOR INTRAMUSCULAR ROUTE OF ADMINISTRATION, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 95 EUROPE: AUTOINJECTOR DEVICES MARKET FOR INTRAMUSCULAR ROUTE OF ADMINISTRATION, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 96 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET FOR INTRAMUSCULAR ROUTE OF ADMINISTRATION, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 97 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET FOR INTRAMUSCULAR ROUTE OF ADMINISTRATION, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 98 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET FOR INTRAMUSCULAR ROUTE OF ADMINISTRATION, BY REGION, 2022-2030 (USD MILLION)
TABLE 99 AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 100 AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (MILLION UNITS)
TABLE 101 AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 102 AUTOINJECTOR DEVICES MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 103 AUTOINJECTOR DEVICES MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2022-2030 (MILLION UNITS)
TABLE 104 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET FOR RHEUMATOID ARTHRITIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 105 EUROPE: AUTOINJECTOR DEVICES MARKET FOR RHEUMATOID ARTHRITIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 106 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET FOR RHEUMATOID ARTHRITIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 107 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET FOR RHEUMATOID ARTHRITIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 108 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 109 AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 110 NORTH AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR RHEUMATOID ARTHRITIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 111 EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR RHEUMATOID ARTHRITIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 112 ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR RHEUMATOID ARTHRITIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 113 LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR RHEUMATOID ARTHRITIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 114 MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 115 AUTOINJECTOR DEVICES MARKET FOR DIABETES, BY REGION, 2022-2030 (USD MILLION)
TABLE 116 AUTOINJECTOR DEVICES MARKET FOR DIABETES, BY REGION, 2022-2030 (MILLION UNITS)
TABLE 117 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET FOR DIABETES, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 118 EUROPE: AUTOINJECTOR DEVICES MARKET FOR DIABETES, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 119 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET FOR DIABETES, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 120 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET FOR DIABETES, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 121 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET FOR DIABETES, BY REGION, 2022-2030 (USD MILLION)
TABLE 122 AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR DIABETES, BY REGION, 2022-2030 (USD MILLION)
TABLE 123 NORTH AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR DIABETES, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 124 EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR DIABETES, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 125 ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR DIABETES, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 126 LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR DIABETES, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 127 MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR DIABETES, BY REGION, 2022-2030 (USD MILLION)
TABLE 128 AUTOINJECTOR DEVICES MARKET FOR MULTIPLE SCLEROSIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 129 AUTOINJECTOR DEVICES MARKET FOR MULTIPLE SCLEROSIS, BY REGION, 2022-2030 (MILLION UNITS)
TABLE 130 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET FOR MULTIPLE SCLEROSIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 131 EUROPE: AUTOINJECTOR DEVICES MARKET FOR MULTIPLE SCLEROSIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 132 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET FOR MULTIPLE SCLEROSIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 133 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET FOR MULTIPLE SCLEROSIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 134 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET FOR MULTIPLE SCLEROSIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 135 AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR MULTIPLE SCLEROSIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 136 NORTH AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR MULTIPLE SCLEROSIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 137 EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR MULTIPLE SCLEROSIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 138 ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR MULTIPLE SCLEROSIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 139 LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR MULTIPLE SCLEROSIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 140 MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR MULTIPLE SCLEROSIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 141 AUTOINJECTOR DEVICES MARKET FOR ANAPHYLAXIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 142 AUTOINJECTOR DEVICES MARKET FOR ANAPHYLAXIS, BY REGION, 2022-2030 (MILLION UNITS)
TABLE 143 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET FOR ANAPHYLAXIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 144 EUROPE: AUTOINJECTOR DEVICES MARKET FOR ANAPHYLAXIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 145 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET FOR ANAPHYLAXIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 146 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET FOR ANAPHYLAXIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 147 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET FOR ANAPHYLAXIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 148 AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR ANAPHYLAXIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 149 NORTH AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR ANAPHYLAXIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 150 EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR ANAPHYLAXIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 151 ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR ANAPHYLAXIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 152 LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR ANAPHYLAXIS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR ANAPHYLAXIS, BY REGION, 2022-2030 (USD MILLION)
TABLE 154 AUTOINJECTOR DEVICES MARKET FOR OBESITY, BY REGION, 2022-2030 (USD MILLION)
TABLE 155 AUTOINJECTOR DEVICES MARKET FOR OBESITY, BY REGION, 2022-2030 (MILLION UNITS)
TABLE 156 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET FOR OBESITY, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 157 EUROPE: AUTOINJECTOR DEVICES MARKET FOR OBESITY, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 158 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET FOR OBESITY, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 159 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET FOR OBESITY, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 160 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET FOR OBESITY, BY REGION, 2022-2030 (USD MILLION)
TABLE 161 AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR OBESITY, BY REGION, 2022-2030 (USD MILLION)
TABLE 162 NORTH AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR OBESITY, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 163 EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR OBESITY, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 164 ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR OBESITY, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 165 LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR OBESITY, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 166 MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR OBESITY, BY REGION, 2022-2030 (USD MILLION)
TABLE 167 AUTOINJECTOR DEVICES MARKET FOR OTHER THERAPY AREAS, BY REGION, 2022-2030 (USD MILLION)
TABLE 168 AUTOINJECTOR DEVICES MARKET FOR OTHER THERAPY AREAS, BY REGION, 2022-2030 (MILLION UNITS)
TABLE 169 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET FOR OTHER THERAPY AREAS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 170 EUROPE: AUTOINJECTOR DEVICES MARKET FOR OTHER THERAPY AREAS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 171 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET FOR OTHER THERAPY AREAS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 172 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET FOR OTHER THERAPY AREAS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 173 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET FOR OTHER THERAPY AREAS, BY REGION, 2022-2030 (USD MILLION)
TABLE 174 AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR OTHER THERAPY AREAS, BY REGION, 2022-2030 (USD MILLION)
TABLE 175 NORTH AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR OTHER THERAPY AREAS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 176 EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR OTHER THERAPY AREAS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 177 ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR OTHER THERAPY AREAS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 178 LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR OTHER THERAPY AREAS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET FOR OTHER THERAPY AREAS, BY REGION, 2022-2030 (USD MILLION)
TABLE 180 AUTOINJECTOR DEVICES MARKET, BY VOLUME, 2022-2030 (USD MILLION)
TABLE 181 AUTOINJECTOR DEVICES MARKET, BY VOLUME, 2022-2030 (MILLION UNITS)
TABLE 182 UP TO 3ML VOLUME AUTOINJECTOR DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 183 UP TO 3ML VOLUME AUTOINJECTOR DEVICES MARKET, BY REGION, 2022-2030 (MILLION UNITS)
TABLE 184 ABOVE 3ML VOLUME AUTOINJECTOR DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 185 ABOVE 3ML VOLUME AUTOINJECTOR DEVICES MARKET, BY REGION, 2022-2030 (MILLION UNITS)
TABLE 186 AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 187 AUTOINJECTOR DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2022-2030 (USD MILLION)
TABLE 188 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 189 EUROPE: AUTOINJECTOR DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 190 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 191 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 192 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2022-2030 (USD MILLION)
TABLE 193 AUTOINJECTOR DEVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022-2030 (USD MILLION)
TABLE 194 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 195 EUROPE: AUTOINJECTOR DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 196 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 197 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 198 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022-2030 (USD MILLION)
TABLE 199 AUTOINJECTOR DEVICES MARKET FOR AMBULATORY CARE SETTINGS, BY REGION, 2022-2030 (USD MILLION)
TABLE 200 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 201 EUROPE: AUTOINJECTOR DEVICES MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 202 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 203 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 204 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET FOR AMBULATORY CARE SETTINGS, BY REGION, 2022-2030 (USD MILLION)
TABLE 205 AUTOINJECTOR DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 206 AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 207 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 208 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 209 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 210 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 211 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 212 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET, BY VOLUME, 2022-2030 (USD MILLION)
TABLE 213 NORTH AMERICA: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 214 NORTH AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 215 NORTH AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 216 NORTH AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 217 NORTH AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 218 NORTH AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 219 NORTH AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY VOLUME, 2022-2030 (USD MILLION)
TABLE 220 NORTH AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 221 AUTOINJECTORS APPROVED BY US FDA, 2018-2024
TABLE 222 US: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 223 US: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 224 US: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 225 US: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 226 US: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 227 US: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 228 US: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 229 US: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 230 US: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 231 US: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 232 CANADA: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 233 CANADA: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 234 CANADA: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 235 CANADA: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 236 CANADA: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 237 CANADA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 238 CANADA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 239 CANADA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 240 CANADA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 241 CANADA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 242 EUROPE: AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 243 EUROPE: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 244 EUROPE: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 245 EUROPE: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 246 EUROPE: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 247 EUROPE: AUTOINJECTOR DEVICES MARKET, BY VOLUME, 2022-2030 (USD MILLION)
TABLE 248 EUROPE: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 249 EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 250 EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 251 EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 252 EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 253 EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 254 EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY VOLUME, 2022-2030 (USD MILLION)
TABLE 255 EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 256 GERMANY: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 257 GERMANY: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 258 GERMANY: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 259 GERMANY: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 260 GERMANY: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 261 GERMANY: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 262 GERMANY: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 263 GERMANY: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 264 GERMANY: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 265 GERMANY: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 266 UK: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 267 UK: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 268 UK: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 269 UK: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 270 UK: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 271 UK: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 272 UK: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 273 UK: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 274 UK: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 275 UK: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 276 FRANCE: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 277 FRANCE: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 278 FRANCE: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 279 FRANCE: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 280 FRANCE: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 281 FRANCE: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 282 FRANCE: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 283 FRANCE: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 284 FRANCE: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 285 FRANCE: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 286 ITALY: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 287 ITALY: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 288 ITALY: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 289 ITALY: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 290 ITALY: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 291 ITALY: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 292 ITALY: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 293 ITALY: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 294 ITALY: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 295 ITALY: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 296 SPAIN: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 297 SPAIN: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 298 SPAIN: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 299 SPAIN: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 300 SPAIN: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 301 SPAIN: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 302 SPAIN: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 303 SPAIN: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 304 SPAIN: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 305 SPAIN: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 306 REST OF EUROPE: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 307 REST OF EUROPE: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 308 REST OF EUROPE: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 309 REST OF EUROPE: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 310 REST OF EUROPE: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 311 REST OF EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 312 REST OF EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 313 REST OF EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 314 REST OF EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 315 REST OF EUROPE: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 316 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 317 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 318 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 319 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 320 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 321 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET, BY VOLUME, 2022-2030 (USD MILLION)
TABLE 322 ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 323 ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 324 ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 325 ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 326 ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 327 ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 328 ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY VOLUME, 2022-2030 (USD MILLION)
TABLE 329 ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 330 JAPAN: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 331 JAPAN: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 332 JAPAN: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 333 JAPAN: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 334 JAPAN: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 335 JAPAN: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 336 JAPAN: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 337 JAPAN: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 338 JAPAN: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 339 JAPAN: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 340 CHINA: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 341 CHINA: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 342 CHINA: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 343 CHINA: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 344 CHINA: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 345 CHINA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 346 CHINA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 347 CHINA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 348 CHINA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 349 CHINA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 350 INDIA: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 351 INDIA: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 352 INDIA: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 353 INDIA: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 354 INDIA: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 355 INDIA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 356 INDIA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 357 INDIA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 358 INDIA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 359 INDIA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 360 SOUTH KOREA: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 361 SOUTH KOREA: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 362 SOUTH KOREA: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 363 SOUTH KOREA: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 364 SOUTH KOREA: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 365 SOUTH KOREA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 366 SOUTH KOREA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 367 SOUTH KOREA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 368 SOUTH KOREA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 369 SOUTH KOREA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 370 REST OF ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 371 REST OF ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 372 REST OF ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 373 REST OF ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 374 REST OF ASIA PACIFIC: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 375 REST OF ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 376 REST OF ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 377 REST OF ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 378 REST OF ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 379 REST OF ASIA PACIFIC: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 380 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 381 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 382 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 383 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 384 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 385 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET, BY VOLUME, 2022-2030 (USD MILLION)
TABLE 386 LATIN AMERICA: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 387 LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 388 LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 389 LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 390 LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 391 LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 392 LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY VOLUME, 2022-2030 (USD MILLION)
TABLE 393 LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 394 BRAZIL: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 395 BRAZIL: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 396 BRAZIL: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 397 BRAZIL: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 398 BRAZIL: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 399 BRAZIL: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 400 BRAZIL: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 401 BRAZIL: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 402 BRAZIL: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 403 BRAZIL: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 404 REST OF LATIN AMERICA: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 405 REST OF LATIN AMERICA: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 406 REST OF LATIN AMERICA: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 407 REST OF LATIN AMERICA: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 408 REST OF LATIN AMERICA: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 409 REST OF LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 410 REST OF LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 411 REST OF LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 412 REST OF LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 413 REST OF LATIN AMERICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 414 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 415 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 416 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 417 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 418 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 419 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET, BY VOLUME, 2022-2030 (USD MILLION)
TABLE 420 MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 421 MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 422 MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 423 MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 424 MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 425 MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 426 MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY VOLUME, 2022-2030 (USD MILLION)
TABLE 427 MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 428 GCC COUNTRIES: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 429 GCC COUNTRIES: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 430 GCC COUNTRIES: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 431 GCC COUNTRIES: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 432 GCC COUNTRIES: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 433 GCC COUNTRIES: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 434 GCC COUNTRIES: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 435 GCC COUNTRIES: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 436 GCC COUNTRIES: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 437 GCC COUNTRIES: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 438 REST OF MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 439 REST OF MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 440 REST OF MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 441 REST OF MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 442 REST OF MIDDLE EAST & AFRICA: AUTOINJECTOR DEVICES MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 443 REST OF MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY USAGE, 2022-2030 (USD MILLION)
TABLE 444 REST OF MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION)
TABLE 445 REST OF MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION)
TABLE 446 REST OF MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY THERAPY AREA, 2022-2030 (USD MILLION)
TABLE 447 REST OF MIDDLE EAST & AFRICA: AUTOINJECTOR FINISHED FORMULATIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 448 OVERVIEW OF STRATEGIES DEPLOYED BY KEY AUTOINJECTOR DEVICE MANUFACTURING COMPANIES
TABLE 449 AUTOINJECTOR DEVICES MARKET: DEGREE OF COMPETITION
TABLE 450 AUTOINJECTOR FINISHED FORMULATIONS MARKET: DEGREE OF COMPETITION
TABLE 451 AUTOINJECTOR DEVICES MARKET: REGION FOOTPRINT
TABLE 452 AUTOINJECTOR FINISHED FORMULATIONS MARKET: REGION FOOTPRINT
TABLE 453 AUTOINJECTOR DEVICES MARKET: USAGE FOOTPRINT
TABLE 454 AUTOINJECTOR FINISHED FORMULATIONS MARKET: USAGE FOOTPRINT
TABLE 455 AUTOINJECTOR DEVICES MARKET: VOLUME FOOTPRINT
TABLE 456 AUTOINJECTOR DEVICES MARKET: ROUTE OF ADMINISTRATION FOOTPRINT
TABLE 457 AUTOINJECTOR FINISHED FORMULATIONS MARKET: ROUTE OF ADMINISTRATION FOOTPRINT
TABLE 458 AUTOINJECTORS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 459 AUTOINJECTORS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SME PLAYERS
TABLE 460 AUTOINJECTORS MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-JULY 2024
TABLE 461 AUTOINJECTORS MARKET: DEALS, JANUARY 2021-JULY 2024
TABLE 462 AUTOINJECTORS MARKET: EXPANSIONS,
